Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M d'Incan

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
The British Journal of Dermatology|November 21, 2013
Aplasia cutis congenita with dystrophic epidermolysis bullosa: clinical and mutational studyC Chiaverini, A Charlesworth, A Fernandez, et al.
The British Journal of Dermatology|May 8, 2013
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patientsF Julia, T Petrella, M Beylot-Barry, et al.
Blood|May 26, 1999
Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous LymphomasF Grange, G Hedelin, P Joly, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|February 28, 2002
[Neurofibromatosis 1: recommendations for management]S Pinson, A Créange, S Barbarot, et al.
Annales De Dermatologie Et De Venereologie|June 8, 2001
[Neurofibromatosis 1: recommendations for management]S Pinson, A Créange, S Barbarot, et al.
Journal Francais D'Ophtalmologie|May 16, 2002
[Recommendations for the treatment of neurofibromatosis type 1]S Pinson, A Créange, S Barbarot, et al.
Dermatology (Basel, Switzerland)|January 20, 2004
Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient seraP Joly, Ph Courville, C Lok, et al.
The British Journal of Dermatology|June 26, 2021
International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg<sup>-1</sup> per day starting dose of oral corticosteroids to treat bullous pemphigoidV Hébert, S Bastos, K Drenovska, et al.
Annales De Dermatologie Et De Venereologie|July 20, 2004
[Relationship between clinical findings of patients with bullous pemphigoid and antigens recognized by their circulating antibasement membrane zone antibodies]A Gary, P Carvalho, J-B Louison, et al.
The British Journal of Dermatology|July 8, 2015
Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study GroupC Hurabielle, S Ingen-Housz-Oro, N Ortonne, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
The British Journal of Dermatology|November 21, 2013
Aplasia cutis congenita with dystrophic epidermolysis bullosa: clinical and mutational studyC Chiaverini, A Charlesworth, A Fernandez, et al.
The British Journal of Dermatology|May 8, 2013
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patientsF Julia, T Petrella, M Beylot-Barry, et al.
Blood|May 26, 1999
Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous LymphomasF Grange, G Hedelin, P Joly, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|February 28, 2002
[Neurofibromatosis 1: recommendations for management]S Pinson, A Créange, S Barbarot, et al.
Annales De Dermatologie Et De Venereologie|June 8, 2001
[Neurofibromatosis 1: recommendations for management]S Pinson, A Créange, S Barbarot, et al.
Journal Francais D'Ophtalmologie|May 16, 2002
[Recommendations for the treatment of neurofibromatosis type 1]S Pinson, A Créange, S Barbarot, et al.
Dermatology (Basel, Switzerland)|January 20, 2004
Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient seraP Joly, Ph Courville, C Lok, et al.
The British Journal of Dermatology|June 26, 2021
International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg<sup>-1</sup> per day starting dose of oral corticosteroids to treat bullous pemphigoidV Hébert, S Bastos, K Drenovska, et al.
Annales De Dermatologie Et De Venereologie|July 20, 2004
[Relationship between clinical findings of patients with bullous pemphigoid and antigens recognized by their circulating antibasement membrane zone antibodies]A Gary, P Carvalho, J-B Louison, et al.
The British Journal of Dermatology|July 8, 2015
Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study GroupC Hurabielle, S Ingen-Housz-Oro, N Ortonne, et al.
Pageof 10